Clinical Trial Update: Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

View source ↗

Summary

A post-marketing surveillance study in Japan evaluating long-term use of Ofev (nintedanib) for systemic sclerosis-associated interstitial lung disease (SSc-ILD)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis-associated Interstitial Lung Disease

Drugs mentioned

• OFEV (Nintedanib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Lung Diseases, Interstitial | Status: ACTIVE_NOT_RECRUITING